Is the Hemophilia A drug the Best Proven Treatment?
Hemophilia A drug approval is a significant milestone for patients seeking effective treatment options.
Hemophilia A drug approval is a significant milestone for patients seeking effective treatment options.
HLB Pep Ingredient Approval is now valid in Mexico, marking a significant milestone in pharma advancements.
Midazolam Nasal Spray is now exempt from price control for five years, benefiting patients and the market.
FDA approval ketamine injection is a breakthrough in mental health treatment.
Life-saving drug prices are under scrutiny as Khader urges the Centre for urgent control measures.
High drug prices are raising concerns among patients and healthcare providers, prompting calls for a margin cap.
ACAD stock approval is gaining momentum as CHMP recommends a rare nerve disorder drug in Europe, marking a significant milestone for the company.